Listeria monocytogenes infection in Crohn's disease treated with adalimumab.
Royal Hobart Hospital, Hobart, TAS, Australia. Kaspar.Willson@dhhs.tas.gov.au
Kaspar J
KJ
Willson
Antony
A
Jacob
Mohit P
MP
Shetti
Rajesh
R
Bhatia
Kwang
K
Yee
William
W
Osler
D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D008089:Listeria monocytogenes / Q000302:isolation & purification*; D008088:Listeriosis / Q000209:etiology* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab